44.78
+1.1(+2.52%)
Currency In USD
| Previous Close | 43.68 |
| Open | 43.58 |
| Day High | 45.07 |
| Day Low | 43 |
| 52-Week High | 60.92 |
| 52-Week Low | 36.61 |
| Volume | 634,660 |
| Average Volume | 509,487 |
| Market Cap | 2.05B |
| PE | -10.22 |
| EPS | -4.38 |
| Moving Average 50 Days | 47.05 |
| Moving Average 200 Days | 48.28 |
| Change | 1.1 |
If you invested $1000 in Soleno Therapeutics, Inc. (SLNO) 10 years ago, it would be worth $19.54 as of March 12, 2025 at a share price of $44.78. Whereas If you bought $1000 worth of Soleno Therapeutics, Inc. (SLNO) shares 5 years ago, it would be worth $275.15 as of March 12, 2025 at a share price of $44.78.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Soleno Therapeutics to Participate in Upcoming February Investor Conferences
GlobeNewswire Inc.
Jan 29, 2025 9:05 PM GMT
REDWOOD CITY, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will p
Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC
GlobeNewswire Inc.
Dec 17, 2024 9:05 PM GMT
Up to $200 million financing, includes $50 million upfrontREDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the tr
Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 27, 2024 1:00 PM GMT
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that managemen